PetVivo Stock (NASDAQ:PETV)
Previous Close
$0.53
52W Range
$0.29 - $2.19
50D Avg
$0.59
200D Avg
$0.83
Market Cap
$11.94M
Avg Vol (3M)
$22.84K
Beta
2.55
Div Yield
-
PETV Company Profile
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
PETV Performance
Peer Comparison
| Ticker | Company |
|---|---|
| AIMD | Ainos, Inc. |
| TLIS | Talis Biomedical Corporation |
| INVO | INVO Bioscience, Inc. |
| LNSR | LENSAR, Inc. |
| NXL | Nexalin Technology, Inc. |
| NVNO | enVVeno Medical Corporation |
| IRIX | IRIDEX Corporation |
| SRDX | Surmodics, Inc. |
| OSA | ProSomnus, Inc. Common Stock |
| AZYO | Elutia Inc. |
| BJDX | Bluejay Diagnostics, Inc. |
| MOTS | Motus GI Holdings, Inc. |
| TNON | Tenon Medical, Inc. |